Home / Organizations / Hoffmann La Roche

Hoffmann La Roche

On October 1, 1896, at the age of 28, Fritz Hoffmann La Roche launched Hoffmann La Roche company as the successor company to Hoffmann, Traub & Co in Basel, Switzerland. F. Hoffmann La Roche AG is a global health-care company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company is Roche Holding AG. Now company also owns the American biotechnology company Genentech, which is a wholly owned affiliate, and the Japanese biotechnology company Chugai Pharmaceuticals as well as the Tucson, Arizona-based Ventana.

Roche is the third-largest pharma company worldwide. They are also the world’s number 1 in biotech with 14 biopharmaceuticals on the market. Over half of the compounds in their product pipeline are biopharmaceuticals. Roche is one of the few companies increasing their dividend every year, for 2013 as the 27th consecutive year.

Product Portfolio:

  • Anaprox
  • Bactrim
  • Fuzeon
  • Herceptin
  • MabThera
  • Tamiflu
  • Valium
  • Accu-Check 360
  • Discovery XT
  • Symphony
  •  Urisys and many more

Company Information

Type Aktiengesellschaft
Traded as SIX: ROG, OTCQX: RHHBY
Industry Pharmaceuticals
Founded 1896
Founder Fritz Hoffmann-La Roche
Headquarters Basel, Switzerland
Key people Christoph Franz (Chairman of the board),
Severin Schwan (CEO),
Daniel O’Day (COO, Pharmaceuticals),
Roland Diggelmann (COO, Diagnostics)
Products Pharmaceuticals and diagnostics
Revenue 47.462 billion Swiss francs (CHF) (2014)
Net income CHF 9.535 billion (2014)
Number of employees 88,509 (2014)
Subsidiaries Genentech, Ventana
Website www.roche.com

Check Also

Valeant Pharmaceuticals

Valeant Pharmaceuticals is a publicly traded pharmaceutical company based in Montreal, Canada. The company has …